Skip to content

Study · Case report or series · n = 1 · 2024

1 result

Super response to liraglutide in people with obesity: A case report and literature review.

Gutiérrez Medina S, Sánchez Campayo E, Guadalix S, Escalada J

Endocrinologia, diabetes y nutricion1 Dec 2024Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In one patient with grade 4 obesity, weight loss of 40% was achieved at 1 year with hygienic-dietary measures and liraglutide.

    In plain wordsIn one patient with severe obesity, weight loss of 40% at 1 year was reported with diet measures and liraglutide.

    Outcome
    DecreaseWeight loss at 1 year
    Study

    n = 1

    Outcome group
    Body weight · Metabolic and weight
    Studied dose
    Dose not stated · 1 yearAs given in this study (human).

    Measurements

    Weight loss
    40%
    1 year

    Source sentences

    Summary
    achieved an initial weight loss of 40% at 1 year with hygienic-dietary measures and drug treatment with liraglutide.
    1 context sentence
    Summary · context
    In this article, we present the case of a patient with grade 4 obesity (initial body mass index, 50.2kg/m2) with associated mechanical and metabolic complications who achieved an initial weight loss of 40% at 1 year with hygienic-dietary measures and drug treatment with liraglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.